Association between idiopathic premature ovarian failure and fragile X premutation.
about
The fragile-X premutation: a maturing perspective.Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee ofThe FMR1 gene, infertility, and reproductive decision-making: a reviewLinkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age.FMR1 premutation is an uncommon explanation for premature ovarian failure in Han Chinese.Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study.Premature ovarian failure in the fragile X syndrome.Cytogenetics of premature ovarian failure: an investigation on 269 affected women.Initiation of translation of the FMR1 mRNA Occurs predominantly through 5'-end-dependent ribosomal scanningDepression in women with spontaneous 46, XX primary ovarian insufficiency.Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiencyElevated FMR1 mRNA in premutation carriers is due to increased transcription.Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disordersGerm cell-specific Atg7 knockout results in primary ovarian insufficiency in female mice.Somatic expansion in mouse and human carriers of fragile X premutation alleles.The fragile X continuum: new advances and perspectives.Spontaneous premature ovarian failure: management challenges.Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinningPopulation-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency.Identification of genes promoting skin youthfulness by genome-wide association study.Female-specific factors for IHD: across the reproductive lifespan.Current concepts in premature ovarian insufficiency.The impact of FMR1 gene mutations on human reproduction and development: a systematic review.Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics.Examination of reproductive aging milestones among women who carry the FMR1 premutation.Four sisters compound heterozygotes for the pre- and full mutation in fragile X syndrome and a complete inactivation of X-functional chromosome: implications for genetic counseling.Menopausal symptoms and the metabolic syndrome in Nigerian women with type 2 diabetes mellitus.Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation?Association between fragile X premutation and premature ovarian failure: a case-control study and meta-analysis.Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation.Ablation of beta subunit of protein kinase CK2 in mouse oocytes causes follicle atresia and premature ovarian failure.
P2860
Q24533443-AE4E63DC-2AA3-471F-B040-6E69E1F94585Q24621437-7F578213-1E7B-49D5-BE6B-EE38E834B6E4Q27026782-05AFB5CD-E830-45B3-ABA3-D6921B7A752BQ33910994-65504EFB-8CD9-4FB7-A09A-824A9E7DC454Q33933573-EFC8B95A-D8C6-4CAD-9EDA-EC8D3F7864A9Q34013270-F2580CA4-68A3-4C69-8FC7-8BFFA0D95EF9Q34306135-9AA6E89D-947B-4F24-B126-4128A20486C1Q34521311-8870D425-8514-486B-ADAA-1C59DF88DE76Q34612704-EE1685B3-9BF7-4325-BEF5-0CBFE89D24DEQ34622530-9C55B3CF-4826-4B02-B691-36C5B083D2BBQ35230078-0157D321-A044-4F3A-A495-86DF7F6758F9Q35697473-B3AF0CF4-1F86-422E-8F92-E43F68B9C6F4Q36085633-5E3EE257-E953-4D3D-9B66-B4C9E830EB50Q36338209-468CFE3D-6FA8-4FC0-83F9-C46B28CEC177Q36347125-AF17F7E7-826C-4437-903A-A92B96AFAF7AQ36472667-659EBDFF-5700-4F4A-82DE-E13DF808FCDAQ37150380-48649057-0EF7-4BA5-A5AD-670724283C48Q37196552-AB295BB1-0117-40B5-A106-086BBB86BDF9Q37291548-4AAD90D8-C5DB-48FC-A317-A758621A88BAQ37555606-DB7C23BD-A7EA-4F4A-89DD-FB20F8392913Q37581750-128435A1-A762-44CB-A36C-E685C3A940EAQ38332049-B80DE74C-B91F-4575-9EF9-AC7BE9E2F259Q38380077-8211DE0C-388E-4B13-A8AC-D819A1FF42D1Q38901729-73AC72AB-FFAE-4C6E-B812-0161A0917267Q40721679-793D55CE-BB60-4B0A-8A25-ADD59ED2CCF5Q48621332-2220D25F-0F7E-4CE7-9CC3-EFB73BFF3053Q48788754-9FB9C550-391F-44DC-82AF-ADFA07F9CCDDQ50301340-6704A043-2C4C-40E2-8AB9-15E1165412C1Q50605141-C1B92585-E8E5-4A93-B56F-997D039735D1Q50656938-D3061531-17F3-4A08-9D6B-A590190092ABQ50664150-5CB78623-DFFC-448D-A900-1AD6CE57D6AEQ51923151-56B721A5-4A86-498E-8E1A-45283A1B9CE9Q54979797-9328BED1-528C-49D4-8500-717DC5D5608E
P2860
Association between idiopathic premature ovarian failure and fragile X premutation.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Association between idiopathic premature ovarian failure and fragile X premutation.
@en
Association between idiopathic premature ovarian failure and fragile X premutation.
@nl
type
label
Association between idiopathic premature ovarian failure and fragile X premutation.
@en
Association between idiopathic premature ovarian failure and fragile X premutation.
@nl
prefLabel
Association between idiopathic premature ovarian failure and fragile X premutation.
@en
Association between idiopathic premature ovarian failure and fragile X premutation.
@nl
P2093
P2860
P356
P1433
P1476
Association between idiopathic premature ovarian failure and fragile X premutation.
@en
P2093
Crosignani PG
Manfredini E
Meneveri R
Tibiletti MG
P2860
P304
P356
10.1093/HUMREP/15.1.197
P407
P577
2000-01-01T00:00:00Z